InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,891.78
(
-2.42%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

randychub

Send PM Follow Ignore
Followers 26
Posts 2588
Boards Moderated 0
Alias Born 10/23/2003

randychub

Re: rfj1862 post# 246507

Friday, 04/21/2023 8:51:49 PM

Friday, April 21, 2023 8:51:49 PM

Post# of 252501
Seems a bit rich given they don’t have a drug in phase 3 trials yet. If I remember correctly even you didn’t think they woold get this type of bump off of the latest glp1 results. In support I would say the offering did go well.

Does their glp1 have advantages over Rybelsus?

Thanks for your thoughts!!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up